Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva, Novartis - Bloomberg
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Shows Progress on Restructuring But Investors Want More - TheStreet
Teva shares plummet amid CEO departure and bribery reports
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
